tiprankstipranks
Trending News
More News >
Kitanotatsujin Corp. (JP:2930)
:2930
Japanese Market

Kitanotatsujin Corp. (2930) AI Stock Analysis

Compare
1 Followers

Top Page

JP:2930

Kitanotatsujin Corp.

(2930)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 5.2)
Rating:74Outperform
Price Target:
¥153.00
▲(11.68% Upside)
The score is primarily supported by strong financial quality—especially the near debt-free balance sheet and solid margins—tempered by inconsistent growth and cash-flow variability. Technicals are neutral-to-slightly soft versus longer-term averages, and valuation is reasonable with a supportive dividend yield but not a clear bargain.

Kitanotatsujin Corp. (2930) vs. iShares MSCI Japan ETF (EWJ)

Kitanotatsujin Corp. Business Overview & Revenue Model

Company DescriptionKitanotatsujin Corporation plans, develops, manufactures, and sells health foods, cosmetics, and miscellaneous goods in Japan. It offers health foods and beauty products under the J North Farm brand. The company also sell its products through its e-commerce website. Kitanotatsujin Corporation was founded in 2000 and is headquartered in Sapporo, Japan.
How the Company Makes Money

Kitanotatsujin Corp. Financial Statement Overview

Summary
Income Statement
Balance Sheet
Cash Flow
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue11.15B11.83B14.67B9.83B9.51B9.27B
Gross Profit8.50B8.97B10.83B7.30B7.17B7.02B
EBITDA1.67B1.86B1.64B661.41M2.16B2.05B
Net Income1.11B1.21B994.66M343.67M1.34B1.39B
Balance Sheet
Total Assets8.79B9.16B8.65B7.78B7.56B6.20B
Cash, Cash Equivalents and Short-Term Investments5.15B5.70B4.78B4.83B5.21B3.61B
Total Debt0.000.0022.53M52.76M53.80M0.00
Total Liabilities1.06B1.29B1.65B1.59B1.41B1.02B
Stockholders Equity7.73B7.87B7.00B6.19B6.15B5.18B
Cash Flow
Free Cash Flow0.001.65B301.94M8.48M1.72B654.53M
Operating Cash Flow0.001.81B453.69M113.64M1.75B682.35M
Investing Cash Flow0.00-530.93M-277.77M-141.01M197.94M-609.82M
Financing Cash Flow0.00-366.96M-223.53M-363.13M-363.02M-555.07M

Kitanotatsujin Corp. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥20.01B20.942.89%
68
Neutral
¥11.53B37.365.92%22.86%-32.11%
63
Neutral
¥6.46B8.332.38%-0.79%
63
Neutral
¥9.64B25.462.65%11.87%-31.02%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
52
Neutral
¥6.24B13.26-19.42%
49
Neutral
¥10.29B-68.280.48%10.13%-14654.18%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:2930
Kitanotatsujin Corp.
143.00
-8.24
-5.45%
JP:4925
HABA Laboratories, Inc.
1,718.00
140.76
8.92%
JP:4932
Almado, Inc.
1,146.00
22.63
2.01%
JP:4934
Premier Anti-Aging Co., Ltd.
707.00
-112.00
-13.68%
JP:4935
Liberta Co., Ltd.
321.00
-412.92
-56.26%
JP:4936
AXXZIA, Inc.
401.00
-34.41
-7.90%

Kitanotatsujin Corp. Corporate Events

Kitanotatsujin Enhances Shareholder Benefit Program with New Product Offering
Dec 15, 2025

Kitanotatsujin Corporation has announced an enhancement to its shareholder benefit program, effective for the fiscal year ending February 28, 2026. The changes include offering the new ‘YOIPEEL’ soft peeling booster serum to all shareholders holding at least 100 shares, along with vouchers for purchases on their exclusive online store. This initiative aims to increase shareholder engagement and promote the company’s products, potentially boosting its market attractiveness and shareholder loyalty.

Kitanotatsujin Corp. Announces Subsidiary Name Change and Officer Transfers
Dec 1, 2025

Kitanotatsujin Corporation announced a change in the trade name of its subsidiary, Rebirth Chain Consulting Co., Ltd., to KARAKON DIRECT Co., Ltd., aiming to enhance corporate value by aligning the subsidiary’s name with its core business. Additionally, the company has executed a transfer of officers to strengthen its corporate governance structure, with new appointments made to key positions to improve oversight and corporate value.

Kitanotatsujin Corp. Acquires Rebirth Chain Consulting to Boost E-commerce Growth
Nov 17, 2025

Kitanotatsujin Corporation announced its decision to acquire Rebirth Chain Consulting Co., Ltd., a company specializing in the color contact lens market, to make it a subsidiary. This acquisition aligns with Kitanotatsujin’s growth strategy to expand its product lineup and improve customer lifetime value, leveraging its expertise in advertising optimization to enhance RC’s profitability and competitiveness in e-commerce malls.

Kitanotatsujin Corp. Reports Q2 Financial Results
Oct 16, 2025

Kitanotatsujin Corporation held a financial results meeting for the second quarter of the fiscal year ending February 28, 2026. The meeting, led by Representative Director & President Katsuhisa Kinoshita, covered highlights of the quarter, major products, an analysis of operating results, and a financial results forecast, followed by a Q&A session.

Kitanotatsujin Corp. Reports Decline in Financial Performance for H1 2025
Oct 15, 2025

Kitanotatsujin Corporation reported a significant decline in its financial performance for the six months ending August 31, 2025, with net sales, operating profit, ordinary profit, and profit attributable to owners of the parent all showing substantial year-on-year decreases. Despite the downturn, the company maintains a strong equity ratio and plans to continue dividend payments, indicating a stable financial position and commitment to shareholder returns.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 04, 2026